Contact:   Kelly Peuquet
                 National Coalition on Health Care
                 [email protected]
                 202-638-7151, ext. 106

NCHC Applauds Senate Finance Investigation of Drug Pricing

Statement from National Coalition on Health Care’s CEO John Rother on Senate Finance Committee leadership’s demand for transparency on the astronomical pricing of Gilead’s new hepatitis C drug Sovaldi.

“Over the past months, our efforts have been focused on shining light on unsustainable prices. We believe providing more transparency into how and why drugs are priced is critical to the long-term sustainability and innovation that is a hallmark of a strong health care system. We applaud Senator Grassley and Senator Wyden for undertaking this critical investigation of high prices for certain prescription drugs.”

###

The National Coalition on Health Care(NCHC), the oldest and most diverse group working to achieve comprehensive health system reform, is a 501(c)(3) organization representing more than 80 participating organizations, including medical societies, businesses, unions, health care providers, faith-based associations, pension and health funds, insurers and groups representing consumers, patients, women, minorities and persons with disabilities. Member organizations collectively represent – as employees, members, or congregants – over 100 million Americans.

Some members of NCHC do not, or cannot, take positions either on specific legislation, strategies or on any policies outside their respective mission areas. However, all that can, do endorse broad policy positions in support of comprehensive health system change.

FILED UNDER: UNCATEGORIZED

NCHC Applauds Senate Finance Investigation of Drug Pricing

JULY 11, 2014 BY LARRY MCNEELY

NCHC Applauds Senate Finance Investigation of Drug Pricing

Statement from National Coalition on Health Care’s CEO John Rother on Senate Finance Committee leadership’s demand for transparency on the astronomical pricing of Gilead’s new hepatitis C drug Sovaldi.

“Over the past months, our efforts have been focused on shining light on unsustainable prices. We believe providing more transparency into how and why drugs are priced is critical to the long-term sustainability and innovation that is a hallmark of a strong health care system.  We applaud Senator Grassley and Senator Wyden for undertaking this critical investigation of high prices for certain prescription drugs.”

See full press release: https://nchc.org/nchc-applauds-senate-finance-investigation-of-drug-pricing-2